Literature DB >> 18976906

Synthesis and evaluation of a series of homologues of lobelane at the vesicular monoamine transporter-2.

Guangrong Zheng1, Linda P Dwoskin, Agripina G Deaciuc, Peter A Crooks.   

Abstract

A series of lobelane homologues has been synthesized and evaluated for their [(3)H]DTBZ binding affinity at the vesicular monoamine transporter-2 (VMAT2). The structure-activity relationships (SAR) indicate that for retention of binding affinity at VMAT2, the lengths of the methylene linkers should be no shorter than one methylene unit at C-6 of the piperidine ring, and no shorter than two methylene units at C-2 of the piperidine ring. These results indicate that the intramolecular distances between the piperidine ring and two phenyl rings in lobelane analogues are an important criterion for retention of high affinity at VMAT2.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18976906      PMCID: PMC3652799          DOI: 10.1016/j.bmcl.2008.10.042

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  10 in total

1.  Synthesis and evaluation of a series of tropane analogues as novel vesicular monoamine transporter-2 ligands.

Authors:  Guangrong Zheng; Linda P Dwoskin; Agripina G Deaciuc; Peter A Crooks
Journal:  Bioorg Med Chem Lett       Date:  2005-10-15       Impact factor: 2.823

Review 2.  A novel mechanism of action and potential use for lobeline as a treatment for psychostimulant abuse.

Authors:  Linda P Dwoskin; Peter A Crooks
Journal:  Biochem Pharmacol       Date:  2002-01-15       Impact factor: 5.858

3.  Easily prepared air- and moisture-stable Pd-NHC (NHC=N-heterocyclic carbene) complexes: a reliable, user-friendly, highly active palladium precatalyst for the Suzuki-Miyaura reaction.

Authors:  Christopher J O'Brien; Eric Assen B Kantchev; Cory Valente; Niloufar Hadei; Gregory A Chass; Alan Lough; Alan C Hopkinson; Michael G Organ
Journal:  Chemistry       Date:  2006-06-14       Impact factor: 5.236

4.  A user-friendly, all-purpose Pd-NHC (NHC=N-heterocyclic carbene) precatalyst for the negishi reaction: a step towards a universal cross-coupling catalyst.

Authors:  Michael G Organ; Stephanie Avola; Igor Dubovyk; Niloufar Hadei; Eric Assen B Kantchev; Christopher J O'Brien; Cory Valente
Journal:  Chemistry       Date:  2006-06-14       Impact factor: 5.236

5.  Lobeline and nicotine evoke [3H]overflow from rat striatal slices preloaded with [3H]dopamine: differential inhibition of synaptosomal and vesicular [3H]dopamine uptake.

Authors:  L Teng; P A Crooks; P K Sonsalla; L P Dwoskin
Journal:  J Pharmacol Exp Ther       Date:  1997-03       Impact factor: 4.030

6.  Lobelane analogues as novel ligands for the vesicular monoamine transporter-2.

Authors:  Guangrong Zheng; Linda P Dwoskin; Agripina G Deaciuc; Jun Zhu; Marlon D Jones; Peter A Crooks
Journal:  Bioorg Med Chem       Date:  2005-06-02       Impact factor: 3.641

Review 7.  Vesicular monoamine transporter 2: role as a novel target for drug development.

Authors:  Guangrong Zheng; Linda P Dwoskin; Peter A Crooks
Journal:  AAPS J       Date:  2006-11-10       Impact factor: 4.009

8.  Defunctionalized lobeline analogues: structure-activity of novel ligands for the vesicular monoamine transporter.

Authors:  Guangrong Zheng; Linda P Dwoskin; Agripina G Deaciuc; Seth D Norrholm; Peter A Crooks
Journal:  J Med Chem       Date:  2005-08-25       Impact factor: 7.446

9.  Lobeline displaces [3H]dihydrotetrabenazine binding and releases [3H]dopamine from rat striatal synaptic vesicles: comparison with d-amphetamine.

Authors:  L Teng; P A Crooks; L P Dwoskin
Journal:  J Neurochem       Date:  1998-07       Impact factor: 5.372

10.  Lobelane decreases methamphetamine self-administration in rats.

Authors:  Nichole M Neugebauer; Steven B Harrod; Dustin J Stairs; Peter A Crooks; Linda P Dwoskin; Michael T Bardo
Journal:  Eur J Pharmacol       Date:  2007-06-13       Impact factor: 4.432

  10 in total
  10 in total

Review 1.  Design, synthesis and interaction at the vesicular monoamine transporter-2 of lobeline analogs: potential pharmacotherapies for the treatment of psychostimulant abuse.

Authors:  Peter A Crooks; Guangrong Zheng; Ashish P Vartak; John P Culver; Fang Zheng; David B Horton; Linda P Dwoskin
Journal:  Curr Top Med Chem       Date:  2011       Impact factor: 3.295

2.  Lobelane analogues containing 4-hydroxy and 4-(2-fluoroethoxy) aromatic substituents: Potent and selective inhibitors of [(3)H]dopamine uptake at the vesicular monoamine transporter-2.

Authors:  Shyamsunder R Joolakanti; Justin R Nickell; Venumadhav Janganati; Guangrong Zheng; Linda P Dwoskin; Peter A Crooks
Journal:  Bioorg Med Chem Lett       Date:  2016-04-01       Impact factor: 2.823

3.  Stereocontrolled synthesis and pharmacological evaluation of cis-2,6-diphenethyl-1-azabicyclo[2.2.2]octanes as lobelane analogues.

Authors:  Guangrong Zheng; Linda P Dwoskin; Agripina G Deaciuc; Peter A Crooks
Journal:  J Org Chem       Date:  2009-08-21       Impact factor: 4.354

4.  Synthesis of Lobeline, Lobelane and their Analogues. A Review.

Authors:  Guangrong Zheng; Peter A Crooks
Journal:  Org Prep Proced Int       Date:  2015-08-17       Impact factor: 1.628

5.  Quinlobelane: a water-soluble lobelane analogue and inhibitor of VMAT2.

Authors:  Ashish P Vartak; A Gabriela Deaciuc; Linda P Dwoskin; Peter A Crooks
Journal:  Bioorg Med Chem Lett       Date:  2010-05-04       Impact factor: 2.823

6.  The novel pyrrolidine nor-lobelane analog UKCP-110 [cis-2,5-di-(2-phenethyl)-pyrrolidine hydrochloride] inhibits VMAT2 function, methamphetamine-evoked dopamine release, and methamphetamine self-administration in rats.

Authors:  Joshua S Beckmann; Kiran B Siripurapu; Justin R Nickell; David B Horton; Emily D Denehy; Ashish Vartak; Peter A Crooks; Linda P Dwoskin; Michael T Bardo
Journal:  J Pharmacol Exp Ther       Date:  2010-08-30       Impact factor: 4.030

7.  Exploring the effect of N-substitution in nor-lobelane on the interaction with VMAT2: discovery of a potential clinical candidate for treatment of methamphetamine abuse.

Authors:  Guangrong Zheng; David B Horton; Narsimha Reddy Penthala; Justin R Nickell; John P Culver; Agripina G Deaciuc; Linda P Dwoskin; Peter A Crooks
Journal:  Medchemcomm       Date:  2013-03       Impact factor: 3.597

8.  Pyrrolidine analogues of lobelane: relationship of affinity for the dihydrotetrabenazine binding site with function of the vesicular monoamine transporter 2 (VMAT2).

Authors:  Ashish P Vartak; Justin R Nickell; Jaturaporn Chagkutip; Linda P Dwoskin; Peter A Crooks
Journal:  J Med Chem       Date:  2009-12-10       Impact factor: 7.446

9.  Pyrrolidine analogs of GZ-793A: synthesis and evaluation as inhibitors of the vesicular monoamine transporter-2 (VMAT2).

Authors:  Narsimha Reddy Penthala; Purushothama Rao Ponugoti; Justin R Nickell; Agripina G Deaciuc; Linda P Dwoskin; Peter A Crooks
Journal:  Bioorg Med Chem Lett       Date:  2013-04-02       Impact factor: 2.823

10.  Efficient synthesis of cis-2,6-di-(2- quinolylpiperidine).

Authors:  Derong Ding; Linda P Dwoskin; Peter A Crooks
Journal:  Tetrahedron Lett       Date:  2013-09-18       Impact factor: 2.415

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.